NR4A1 and neoplasm: In addition, the prognoses and survival rates of patients are worse in developing countries due to a higher incidence of poor prognostic factors [including triple-negative BC (TNBC), tumor grade and proliferative indexes, and low hormone receptor (HR) positivity statuses], diagnoses at advanced stages and insufficient treatment regimens.